Page last updated: 2024-11-02

piracetam and Acid beta-Glucosidase Deficiency

piracetam has been researched along with Acid beta-Glucosidase Deficiency in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
"We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease."7.78Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012)
"We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease."3.78Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaca, GF1
Lenz, T1
Knight, EM1
Tuxhorn, I1

Other Studies

1 other study available for piracetam and Acid beta-Glucosidase Deficiency

ArticleYear
Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
    Epileptic disorders : international epilepsy journal with videotape, 2012, Volume: 14, Issue:2

    Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Gaucher Disease; Humans;

2012